Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps1-03-09 | Miscellaneous 1 | ETA2023

Iodine nutrition in greenland: urinary iodine concentration during a 20-year period

Andersen Stig , Noahsen Paneeraq , Fleischer Rex Karsten , Mulvad Gert , Christian Florian Sorensen Hans , Linding Andersen Stine

Background: Iodine nutrition relies on dietary intake. Marine foods are iodine rich, and they contributed markedly to the iodine intake among populations in Greenland. However, dietary habits are drifting away from the traditional diet dominated by iodine rich marine foods such as seal, whale, and seabirds. This led us to monitor iodine nutrition among populations in Greenland.Methods: Cohort studies were conducted in 1998, 2008, and 2018 including 50-69...

ea0077p151 | Adrenal and Cardiovascular | SFEBES2021

Iatrogenic Cushing’s syndrome due to betamethasone nasal drops

Alameri Majid , Alnuaimi Abdulla , Patel Kalpesh , Meeran Karim , Wernig Florian

Introduction: Iatrogenic Cushing’s syndrome (ICS) can be caused by virtually all forms of steroid treatment with or without suppression of hypothalamic–pituitary–adrenal (HPA) axis. Here we report betamethasone nasal drops used as treatment post septorhinoplasty as a cause of iatrogenic Cushing’s syndrome.Case: A 36 years old female with background history of depression presented to endocrinology clinic for evaluation of progressive w...

ea0037ep37 | Adrenal cortex | ECE2015

Pregnancy-induced Cushing's syndrome

Andreescu Corina , Hofland Leo , Hofland Hans , Looijenga Leendert , de Herder Wouter , Feelders Richard

Cushing’s syndrome (CS) during pregnancy is a rare metabolic condition with only a few cases reported in the literature. Misdiagnosis of CS is common because of the overlapping features of fatigue, weight gain, striae, and emotional changes that occur during normal pregnancy. The clinical presentation together with laboratory and imaging findings help to make a diagnosis. However, changes in maternal hormones and their binding proteins complicate assessment of the normal ...

ea0014p446 | (1) | ECE2007

Pseudophaeochromocytoma in Parkinson’s disease

Müssig Karsten , Pfäfflin Albrecht , Knaus-Dittmann Daniele , Horger Marius , Mörike Klaus , Häring Hans-Ulrich , Schleicher Erwin D

Objective: Despite combination with peripheral decarboxylase inhibitors significant amounts of L-dopa are peripherally metabolised. In patients with Parkinson’s disease (PD) treated with L-dopa and a dopa decarboxylase inhibitor, urinary dopamine concentrations are markedly elevated. We describe here a L-dopa treated PD patient presenting with a clinical and biochemical picture suspicious of phaeochromocytoma.Case report: A 73-year-old female patien...

ea0073aep804 | Late Breaking | ECE2021

Effects of Christian Orthodox versus intermittent fasting on plasma irisin concentrations in overweight adults

Karras Spyridon , Koufakis Theocharis , Adamidou Lilian , Dimakopoulos Georgios , Karalazou Paraskevi , Thisiadou Katerina , Makedou Kali , Kotsa Kalliopi

Irisin is an adipomyokine produced during physical activity and implicated in the browning of adipose tissue. Existing evidence suggests an inverse relationship between irisin plasma levels and adverse metabolic outcomes; however, the exact impact of diet on irisin levels remains unclear. We aimed to assess the effects of two dietary patterns, Christian Orthodox fasting (OF) and 16:8 time-restricted eating (TRE), on irisin concentrations among overweight, metabolically healthy...

ea0005oc28 | Brain and Behaviour | BES2003

Follistatin is secreted from pituitary folliculo-stellate cell lines by an ABCA1 transporter

Morris J , Kamitani T , Nishino S , Buckingham J , Christian H

The activin-binding protein follistatin is produced by folliculostellate (FS) cells of the anterior pituitary. FS cells make numerous contacts with the classical endocrine cells of the anterior pituitary including gonadotrophs. Follistatin released from the FS cells could therefore play a role in the regulation of gonadotrophin secretion, in particular of FSH. We have previously shown by confocal microscopy (1) that annexin 1, which is also produced by FS cells, is secreted fr...

ea0013p51 | Clinical practice/governance and case reports | SFEBES2007

Medical treatment in adrenal insufficiency: Does the patient’s quality of life differ depending on which glucocorticoid is given?

Bleicken Benjamin , Ventz Manfred , Strasburger Christian J , Quinkler Marcus

Objective: Patients from FRG and West-Berlin with primary (1AI) or secondary (2AI) adrenal insufficiency were treated with hydrocortisone (HC) while in contrast patients from the former GDR received prednisolone (PR). Investigation of our study is to detect any differences in quality of life (QoL) in patients on HC or PR medication.Methods: 350 patients of our outpatient clinic were contacted by mail. Up to now 131 patients took part in the survey. 2 sta...

ea0014p583 | (1) | ECE2007

The endocrine and behavioural actions of neuromedine S

Jászberényi Miklós , Bagosi Zsolt , Szabó Gyula , Telegdy Gyula

Since earlier publications revealed a prominent and versatile impact of the neuromedin peptide family on several neuroendocrine processes, in the present experiments we focused on the effects of a recently discovered member of neuromedines, neuromedine S on such phenomena as open-field behaviour and hypothalamic-pituitary-adrenal (HPA) activation. The peptide was administered intracerebroventricularly to freely moving rats and 30 minutes later the aforementioned neuronedocrine...

ea0011p98 | Clinical case reports | ECE2006

Hypocalcemic cardiomyopathy in a patient with primary hypoparathyroidism and Fahr’s disease

Azzoug S , Chentli F

Hypocalcemic cardiomyopathy due to hypoparathyroidism is a very rare condition which responds favorably to vitaminocalcic treatment.We report the case of a 50 years old man who presented to our unit for general fatigue, apathy and cough lasting several years with a worsening during the last months, there was biological evidence of hypoparathyroidism with profound hypocalcemia (21 mg/l) hyperphosphoremia (53 mg/l) and undetectable PTH levels the CT scan s...

ea0094p81 | Neuroendocrinology and Pituitary | SFEBES2023

Osilodrostat: Effective and Safe Management of ACTH-Dependent Cushing’s Syndrome - A UK single centre experience

Htut Zin , Wernig Florian

We present three cases of ACTH-dependent Cushing’s syndrome, successfully managed with osilodrostat.Case 1: A 42-year-old woman diagnosed with ACTH-dependent Cushing’s disease was initially treated with osilodrostat dose-titration approach, as MRI of the pituitary did not identify a clear surgical target. By week five, serum cortisol levels fully normalised. Salivary and 24 hr urinary free cortisol (UFC) normalised on a mainten...